A recent study shows that elevated circulating levels of TGF-β and CXCL1 are associated with a poor prognosis, and higher detection of circulating tumor cells and propensity of these cells to seed lung metastases in patients with breast cancer [67]. This evidence concerns the gene TGFB1 and breast cancer.